1. Lung resections concomitant to coronary artery bypass grafting
- Author
-
G. Furlan, Conti F, Magnanelli G, P. Chiavacci, N. Ivic, Petrilli G, and Alberto Terzi
- Subjects
Reoperation ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,Time Factors ,medicine.medical_treatment ,Coronary Disease ,law.invention ,Intraoperative Period ,Postoperative Complications ,law ,Preoperative Care ,Cardiopulmonary bypass ,medicine ,Humans ,Saphenous Vein ,Derivation ,Carcinoma, Small Cell ,Coronary Artery Bypass ,Mammary Arteries ,Pneumonectomy ,Lung cancer ,Vein ,Lung ,business.industry ,General Medicine ,medicine.disease ,Surgery ,Survival Rate ,medicine.anatomical_structure ,Median sternotomy ,Concomitant ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies ,Artery - Abstract
From 1980 through 1993 ten patients underwent concomitant coronary artery bypass grafting and lung resection via median sternotomy. In eight patients a lung malignancy was resected, of which one was a small cell lung cancer. The lung resection was carried out before cardiopulmonary bypass in eight patients and during cardiopulmonary bypass in two. Coronary artery bypass grafting was performed using saphenous vein in eight patients; internal mammary artery was used as arterial conduit in two patients. There was one postoperative death while postoperative complications during hospital stay occurred in two patients. Pulmonary bleeding did not occur in any patient in whom lung resection was performed either before or during cardiopulmonary bypass. Both the patients who had internal mammary artery grafting experienced complications related to an associated lobectomy. A staged procedure is advisable if internal mammary artery has to be used and a lobectomy is required. The long-term survival in the patients with lung cancer was less than expected but the number of patients is too small to draw definite conclusions.
- Published
- 1994